Amussen Hunsaker Associates LLC Baxter International Inc Transaction History

Amussen Hunsaker Associates LLC

$715 Million
Q3 2024

A detailed history of Amussen Hunsaker Associates LLC transactions in Baxter International Inc stock. As of the latest transaction made, Amussen Hunsaker Associates LLC holds 7,431 shares of BAX stock, worth $219,214. This represents 0.04% of its overall portfolio holdings.

Number of Shares

7,431

Previous 7,831 5.11%

Holding current value

$219,214

Previous $261,000 8.05%

% of portfolio

0.04%

Previous 0.04%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$32.85 - $40.26 $13,140 - $16,104	-400 Reduced 5.11%	7,431 $282,000
Q2 2024 Aug 14, 2024	SELL	$32.87 - $43.55 $124,643 - $165,141	-3,792 Reduced 32.62%	7,831 $261,000
Q1 2024 May 15, 2024	BUY	$37.88 - $43.77 $15,152 - $17,508	400 Added 3.56%	11,623 $496,000
Q1 2023 May 15, 2023	BUY	$37.58 - $52.57 $199,174 - $278,621	5,300 Added 89.48%	11,223 $455,000
Q1 2020 May 15, 2020	BUY	$71.57 - $93.3 $423,909 - $552,615	5,923 New	5,923 $480,000
Q4 2019 Feb 14, 2020	SELL	$76.7 - $88.45 $587,982 - $678,057	-7,666 Closed	0 $0
Q3 2019 Nov 15, 2019	BUY	$81.4 - $89.78 $264,794 - $292,054	3,253 Added 73.71%	7,666 $671,000
Q1 2019 May 16, 2019	SELL	$64.48 - $81.31 $96,720 - $121,965	-1,500 Reduced 25.37%	4,413 $359,000
Q4 2018 Feb 19, 2019	SELL	$61.45 - $77.8 $2,642 - $3,345	-43 Reduced 0.72%	5,913 $389,000
Q3 2018 Nov 16, 2018	BUY	$70.71 - $77.75 $3,040 - $3,343	43 Added 0.73%	5,956 $380,000
Q3 2017 Nov 15, 2017	BUY	$59.5 - $64.61 $351,823 - $382,038	5,913	5,913 $371,000

Others Institutions Holding BAX

# of Institutions

1,007

Shares Held

450M

Call Options Held

2.79M

Put Options Held

2.44M

View Full List

About BAXTER INTERNATIONAL INC

Ticker BAX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 504,120,992
Market Cap $14.9B
Description
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...

More about BAX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Amussen Hunsaker Associates LLC, based on Form 13F filings with the SEC.

News

Stay updated on Amussen Hunsaker Associates LLC with notifications on news.

Account

Amussen Hunsaker Associates LLC Baxter International Inc Transaction History